Concepedia

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction

Robert M. Califf, Eric J. Topol, Barry S. George, Jane Boswick, Charles W. Abbottsmith, Kristina N. Sigmon, Richard J. Candela, Ramona Masek, Dean J. Kereiakes, William W. O’Neill,

The American Journal of Medicine · 1988 · 160 citations · 31 references

DOI

Concepts

References

31

The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings

Hiltrud S. Mueller, A. R. DYER, Mark A. Greenberg · 1985 · 3.6K citations

, , +11

The Thrombolysis in Myocardial Infarction (TIMI) Trial

New England Journal of Medicine · 1985 · 3.2K citations

, , +9

EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION

GRUPPOITALIANOPERLOSTUDIODELL · The Lancet · 1986 · 2.5K citations

, , +11

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

Anupama Rao, Craig M. Pratt, Andrew Berke et al. · Journal of the American College of Cardiology · 1988 · 988 citations

, , +17

A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction

Eric J. Topol, Robert M. Califf, Barry S. George et al. · New England Journal of Medicine · 1987 · 945 citations

, , +16